World Drug Report

EQS-News: Can This Company’s Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?

Retrieved on: 
Sunday, November 27, 2022
California Rehabilitation Center, Growth, Heart, Spleen, United Nations Office on Drugs and Crime, THC, WHO, Drug overdose, Tourette syndrome, Hand, Agitation, SUD, Pain, Safety, Brain, Advertising, Chronic pain, Research report, United Nations, PEA, Cocaine, Autism, World Drug Report, National Center for Telehealth & Technology, Rat, Pancreas, Inflammation, Death, Addiction, AMPH, World Health Organization, CNS, Disease, UNODC, Status epilepticus, Crave, CBD, Alzheimer's disease, Disability-adjusted life year, Drug, Research, Therapy, Thyroid, Viatris, CSE, Substance abuse, Animal, Liver, Probability, MEAI, Pharmaceutical industry, Crime

Can This Companys Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?

Key Points: 
  • Can This Companys Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
  • Whether its a problem with opioids, alcohol, cocaine, or even using pain meds, an unchecked addiction can be fatal.
  • Take alcohol abuse, for example; the World Health Organization (WHO) estimates that three million deaths yearly result from the harmful use of alcohol.
  • On Aug. 24, the company announced additional positive preclinical results of its psychedelic-based pharma collaboration for treating cocaine addiction using MEAI.

Pharmacovigilance Global Market Report 2022: Rising Incidences of Adverse Drug Reactions to Spur Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 25, 2022
Health, General Health, Machine learning, ADR, World Drug Report, Drug, Artificiality, Person, Incidence, United Nations, Disulfiram-like drug, Asia-Pacific, Data management, Accenture, UNODC, United Nations Office on Drugs and Crime, Pharmacovigilance, Clinical trial, Artificial intelligence, Compliance, UCB, Automation, Growth, Pharmaceutical industry, Medical device, Crime

The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Points: 
  • The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The growing incidences of adverse drug reactions are expected to propel the growth of the pharmacovigilance market going forward.
  • Pharmacovigilance personnel is primarily responsible for monitoring adverse drug reactions (ADRs) in order to ensure safe drug usage and ensure drug safety prior to approval for public use.
  • Therefore, the growing incidence of adverse drug reactions is promoting the growth of the pharmacovigilance market.

Narcotics Scanner Global Markets Report 2022: Ion Mobility Spectrum Technology, Contraband Detection Equipment, Videoscope Inspection System, & Infrared Spectroscopy - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 2, 2022
Public Policy, Government, Homeland Security, Law Enforcement, Emergency Services, Acquisition, World Drug Report, Korea Institute of Science and Technology, OSI Systems, Bruker, Poverty, Airport, United Nations, Rapiscan Systems, United Nations Office on Drugs and Crime, CDex, Asia-Pacific, Thermo Fisher Scientific, Teledyne Technologies, UNODC, Dangerous, COVID-19, Movement, Narcotic, Organization, Drug, Unemployment, Smiths, Law enforcement, Perspiration, Growth, Time-invariant system, Medical device, 3D printing, Medical imaging, Crime

The narcotics scanner market consists of sales of narcotics scanners by entities (organizations, sole traders, and partnerships) that are used to detect drugs and hazardous substances.

Key Points: 
  • The narcotics scanner market consists of sales of narcotics scanners by entities (organizations, sole traders, and partnerships) that are used to detect drugs and hazardous substances.
  • A Narcotics scanner is a specialized security device utilized for security against the threat of drug smuggling.
  • The technologies involved in narcotics scanners are ion mobility spectrum technology, contraband detection equipment, a video scope inspection system, infrared spectroscopy that is used by various sectors such as airports, sea ports, law enforcement, railway terminal, defense and military, others.
  • Constant surge in the number of drug users is significantly contributing to the growth of the narcotics scanner market.

Narconon Latinoamerica Recognized by the Municipal President of Villa Victoria in Recognition of 6th Anniversary

Retrieved on: 
Thursday, October 7, 2021
United Nations, Crime, COVID-19, Letter, GLOBE, Hospital, Emergency, Rehabilitation, World Drug Report, Solution, Spokane Public Facilities District, United Nations Office on Drugs and Crime, Government, Organization, Environment, Residential care, Drug

VILLA VICTORIA, Mexico, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Municipal President of Villa Victoria,Mr.

Key Points: 
  • VILLA VICTORIA, Mexico, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Municipal President of Villa Victoria,Mr.
  • The President stated, "This global event [the pandemic] has taken its toll on vulnerable populations, with addiction becoming the refuge.
  • It is always welcome and comforting to have organizations like Narconon Latinoamerica that offer effective solutions to the drug abuse crisis.
  • Narconon Latinoamerica is an integral part of the Villa Victoria community.Built in 1880, thefacility grounds lie on four acres in beautiful Villa Victoria.

Global Drug Testing Market Analysis Report 2021: Focus on Development of Innovative Testing Solutions - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 5, 2021
Health, Medical Supplies, Medical Devices, Government, Aircraft, World Drug Report, Unemployment, Quidel Corporation, Triage, Cocaine, Collection, FDA, Substance abuse, COVID-19, Consumables, UNODC, Directorate General of Civil Aviation (India), Urine, Air travel, Methamphetamine, Sexual abuse, Cannabis, Asia, Safety, Directorate, Tic disorder, Benzodiazepine, Fluorescence, Addiction, Medical device, Drug, Pharmaceutical industry

The "Global Drug Testing Market Size, Share & Trends Analysis Report by Product Type (Consumables, Instruments, Rapid Testing Devices, Services), by Sample Type, by Drug Type, by End Use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Drug Testing Market Size, Share & Trends Analysis Report by Product Type (Consumables, Instruments, Rapid Testing Devices, Services), by Sample Type, by Drug Type, by End Use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
  • As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally.
  • Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products.

$8.5 Billion Worldwide Biopesticides Industry to 2025 - Featuring Bayer, Syngenta & UPL Limited Among Others

Retrieved on: 
Friday, June 26, 2020
Psychoactive drugs, Drugs, Medical specialties, Pseudomonadales, Drug policy, Prodrugs, RTT, Pseudomonas, Psychrophiles, World Drug Report, International Day Against Drug Abuse and Illicit Trafficking, Heroin

8.3.3.1 Pseudomonas Are Broad-Spectrum Biofungicides, Which is Suitable for All Types of Crops

Key Points: 

8.3.3.1 Pseudomonas Are Broad-Spectrum Biofungicides, Which is Suitable for All Types of Crops
8.3.5.1 Yeast and Bacterial Sep. Produce Antagonistic Metabolites to Suppress Pathogenic Fungal Activities

Speech by Alexis Goosdeel: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective

Retrieved on: 
Saturday, June 27, 2020
Agencies of the European Union, Articles, Government, Europol, European Monitoring Centre for Drugs and Drug Addiction, United Nations Office on Drugs and Crime, European Centre for Disease Prevention and Control, World Drug Report, Drug policy of Sweden

Learning the lessons from COVID-19 to strengthen the EU’s preparedness in the perspective of a possible new outbreak of the epidemic, the Directors of the EMCDDA, ECDC and Europol invite the EU institutions and the Member States:to strengthen rapid data collection, information exchange and intelligence, and analysis to inform immediate cross-border public health and security policy and operational responses;to integrate drug-related services into the essential health services at national level, and to provide adequate equipment and tools for frontline workers;to build on the positive results of changes and innovations that have been brought by the practitioners of drugs services in close cooperation with their clients;to maintain the funding and functioning of drug-related services in the post COVID-19 period;to support the development of new tools and methods that are needed to address the new operational and strategic challenges caused by changes in the drug market from production and trafficking to distribution and use;to strengthen cooperation and coordination between institutions and official authorities, both at European and at national level. Occasion: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation the European perspective Thank you Chairperson and colleagues, I am pleased to provide some closing remarks to this CND special event commemorating the United Nations International day against drug abuse and illicit trafficking.

Key Points: 
  • Learning the lessons from COVID-19 to strengthen the EU’s preparedness in the perspective of a possible new outbreak of the epidemic, the Directors of the EMCDDA, ECDC and Europol invite the EU institutions and the Member States:
    • to strengthen rapid data collection, information exchange and intelligence, and analysis to inform immediate cross-border public health and security policy and operational responses;
    • to integrate drug-related services into the essential health services at national level, and to provide adequate equipment and tools for frontline workers;
    • to build on the positive results of changes and innovations that have been brought by the practitioners of drugs services in close cooperation with their clients;
    • to maintain the funding and functioning of drug-related services in the post COVID-19 period;
    • to support the development of new tools and methods that are needed to address the new operational and strategic challenges caused by changes in the drug market from production and trafficking to distribution and use;
    • to strengthen cooperation and coordination between institutions and official authorities, both at European and at national level.
    • Occasion: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation the European perspective Thank you Chairperson and colleagues, I am pleased to provide some closing remarks to this CND special event commemorating the United Nations International day against drug abuse and illicit trafficking.
    • We were privileged to hear the highlights from this years World Drug Report and to take part in a rich, and highly relevant, discussion on the impact of the COVID-19 pandemic on the world drug situation.
    • The EMCDDA would like to align itself with the comments of UNODC and, in particular, our close European partner Europol.
    • In the last three months, using an array of methods, we have been taking the pulse of the impact of COVID-19 in three areas: drug use, drug services and drug markets.
    • Ensuring the ongoing provision of drug treatment services, including opioid substitution medications and other essential medicines to clients, is paramount.
    • More than ever, our objective is to anticipate emerging threats even better and to inform policy, decision-making and operational responses.
    • There is now a critical need to identify areas where rapid adaptations to operational responses and future policies are required.

    • Fasenra - Drug Insights, 2019-2021 - ResearchAndMarkets.com

    Retrieved on: 
    Monday, December 30, 2019
    Health, Pharmaceutical, Health, Clinical research, Articles, Pharmaceutical industry, Design of experiments, Clinical pharmacology, Clinical trial, World Drug Report

    The "Fasenra - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

    Key Points: 
    • The "Fasenra - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
    • Fasenra - Drug Insight, 2019 report provides comprehensive information of the drug, Fasenra.
    • It includes drugs overview, Fasenra mechanism of action, clinical trials, regulatory milestones, deals & Fasenra's partnerships.
    • The report also throws light on Fasenra market competition and emerging therapies in the same space as Fasenra.

    Vosevi - Drug Insights, 2019 - ResearchAndMarkets.com

    Retrieved on: 
    Monday, December 30, 2019
    Health, Pharmaceutical, Health, Clinical research, Articles, Pharmaceutical industry, Design of experiments, Clinical pharmacology, Clinical trial, World Drug Report

    The "Vosevi - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

    Key Points: 
    • The "Vosevi - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
    • Vosevi - Drug Insight, 2019 report provides comprehensive information of the drug, Vosevi.
    • It includes drugs overview, Vosevi mechanism of action, clinical trials, regulatory milestones, deals & Vosevi's partnerships.
    • The report also throws light on Vosevi market competition and emerging therapies in the same space as Vosevi.

    Radicava Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 - ResearchAndMarkets.com

    Retrieved on: 
    Friday, December 27, 2019
    Pharmaceutical, Health, Clinical trials, Health, Clinical research, Articles, Pharmaceutical industry, Design of experiments, Clinical pharmacology, Clinical trial, World Drug Report

    The "Radicava - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

    Key Points: 
    • The "Radicava - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
    • Radicava - Drug Insight, 2019 report provides comprehensive information of the drug, Radicava.
    • It includes drugs overview, Radicava mechanism of action, clinical trials, regulatory milestones, deals & Radicava's partnerships.
    • The report also throws light on Radicava market competition and emerging therapies in the same space as Radicava.